Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process...
Reexamination Certificate
2002-08-28
2009-02-03
Saunders, David A. (Department: 1644)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
C424S184100, C435S068100, C436S547000, C436S548000
Reexamination Certificate
active
07485438
ABSTRACT:
Embodiments of the invention generally provide methods and compositions for producing polyvalent antigens. In one aspect, the invention provides a method for producing a cross-linked antigen. In another aspect, the invention provides a method of using cross-linked products as antigens to immunize animals and induce strong immune responses.
REFERENCES:
patent: 3794630 (1974-02-01), Mullan et al.
patent: 4411888 (1983-10-01), Klipstein et al.
patent: 4544638 (1985-10-01), Siegel
patent: 4758524 (1988-07-01), Bundesen et al.
patent: 5156956 (1992-10-01), Motoki et al.
patent: 5252469 (1993-10-01), Andou et al.
patent: 5420025 (1995-05-01), Takagi et al.
patent: 5726051 (1998-03-01), Fraij et al.
patent: 5827712 (1998-10-01), Yokoyama et al.
patent: 5939385 (1999-08-01), Labroo et al.
patent: 6010871 (2000-01-01), Takahara et al.
patent: 6013498 (2000-01-01), Yokoyama et al.
patent: 6013526 (2000-01-01), Takahara et al.
patent: 6030821 (2000-02-01), Soeda et al.
patent: 6043087 (2000-03-01), Bini et al.
patent: 6100053 (2000-08-01), Bech et al.
patent: 6121013 (2000-09-01), Yamaguchi
patent: 6190879 (2001-02-01), Bech et al.
patent: 6190896 (2001-02-01), Fraij
patent: 6894022 (2005-05-01), Hubbell et al.
patent: 2003/0153043 (2003-08-01), Carr et al.
patent: 2004/0005654 (2004-01-01), Chou
patent: 2004/0254347 (2004-12-01), Lin et al.
patent: 2007/0190578 (2007-08-01), Chen et al.
patent: 0481504 (1992-04-01), None
patent: WO 99/51723 (1999-10-01), None
patent: WO 00/40706 (1999-12-01), None
patent: WO 00/43492 (2000-07-01), None
patent: WO 00/70026 (2000-11-01), None
patent: WO 01/23591 (2001-04-01), None
patent: WO 02/14518 (2002-02-01), None
The Merck Manual, 17thEdition, Merck Research Laboratories, pp. 1395-1398, 1999.
Kudryk B, Bini A, Procyk R, Matsueda GR and Shainoff Jr, “Cross-linking of fibrinogen by tissue transglutaminase: Involvement of the C-termini of the A.alpha.-and .gamma.-chains in formation of A.alpha..gamma.-dyads,” Thromb Haemostas 69(6):1260 (1993).
Gordon Ada, D.Sc., Vaccines and Vaccination. N Engl J Med, vol. 345, No. 14, p. 1042-1053.
Brandt ER, Sriprakash KS, Hobb RI, et al. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian aboriginal population. Nat. Med. 2000-6-455-9.
Nardin EH, Oliveira GA, Calvo-Calle JM, et al. Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccines of defined HLA genotypes. J Infect Dis 2000;182:1486-96.
Watanabe et. al. Efficacy of chemically cross-linked antigens for accelular pertussis vaccine. Vaccine 19, 1199-1203 (2001).
Nancy St. Clair et. al. Cross-linked protein crystals for vaccine delivery. Proc. Natl. Acad. Sci. USA, vol. 96, pp. 9469-9474, Aug. 1999.
Raghunath et al., “Cross-Linking of the Dermo-Epidermal Junction of Skin Regenerating from Keratinocyte Autografts”, J. Clin. Invest., vol. 98, No. 5, pp. 1174-1184, 1996.NO:05 Recombinant SC transglutaminase N-terminal sequence.
Jurgennsen et al., “A New Biological Glue for Cartilage-Cartilage Interfaces: Tissue Transglutaminase”, The Journal of Bone and Joint Surgery, Inc., vol. 79-A, No. 2, Feb. 1997.
de Jong et al: “Purifiacation and Substrate Specificity of Transglutaminases from BloodStreptoverticillium mobaraense” Journal of Agricultural Food Chemistry 2001, vol. 49, pp. 3389-3393.
Washizu et al., “Molecular cloning of the gene for microbial transglutaminase from streptoverticillium and its expression inStreptomyces lividans” Biosci Biotech, Biochem, vol. 58 No. 1, pp. 82-87 (1994).
Pasternack et al., “Bacterial Pro-Transglutaminase fromStreptoverticillium mobaraensePurification, Characterisation and Sequence of the Zymogen” Euo. J. Biochem 1998, vol. 257, pp. 570-576.
Liu et al., “Effect of Transglutaminase-Catalyzed Polymerization of its Emulsifying Properties” Journal of Agricultural Food Chemistry 1999, vol. 47, pp. 1514-1519.
Duran et al., “Purification, Characterisation, and Gene Cloning of Transglutaminase fromStreptoverticillium cinnamoneumCBS 683.68” Biochimie 80 (4) 1998, pp. 313-319.
Kahlem et al., “Peptides Containing Glutamine Repeats as Substrates for Transglutaminase-Catalyzed Cross-Linking: Relevance to Diseases of the Nervous System” Proc. National Academy of Science USA, vol. 93, pp. 14580-14585, Dec. 1996. Cell Biolog.
O'Brien-Simpson et al., “Polymerization of Unprotected Synthetic Peptides: A View toward Synthetic Peptides Vaccines” Journal of American Chemistry Society, 1997, vol. 119, pp. 1183-1188.
Jackson et al., “Free Radical Induced Polymerization of synthetic peptides into polymeric immunogens” Vaccine, vol. 15, No. 15, pp. 1697-1705, 1997.
Kanaji et al., “Primary structure of microbial transglutaminase from Streptoverticillium” J. Biol. Chem. 268, 11565-11572, 1994.
Folk, J. E., and Cole, P. W. Mechanism of action of guinea pig liver transglutaminase. I. Purification and properties of the enzyme: identification of a functional cysteine essential for activity. J Biol Chem. Dec. 10, 1996;241(23):5518-25.
Shi, Q. et al. Expression inEscherichia coliand Purification of Hexahistidine-Tagged Human Tissue Transglutaminase. Protein Expr Purif. Apr. 24, 2002;(3):366-73.
Natsuka, S. et al. Molecular cloning and expression of Caenorhabditis elegans ERp57-homologue with transglutaminase activity. J Biochem (Tokyo). Dec. 2001;130(6):731-5.
Shcmidt et al. Lysine and polyamines are substrates for transglutamination of Rho by theBordetella dermonecrotictoxin. Infection and Immunity Dec. 2001 69(12):7663-70.
Sato, H. et al. “Further studies on the site-specific protein modification by microbial transglutaminase.” Bioconjug Chem. Sep.-Oct. 2001;12(5):701-10.
Suzuki, S. et al. Purification and characterization of novel transglutaminase fromBacillus subtilisspores. Biosci Biotechnol Biochem. Nov. 2000;64(11):2344-51.
Rucker, E. et al. Rapid evaluation and optimization of recombinant protein production using GFP tagging. Protein Expr Purif. Feb. 2001;21(1):220-3.
Eli-Berchoer, L. et al. Effect of intramolecular cross-linking between glutamine-41 and lysine-50 on actin structure and function. J Muscle Res Cell Motil. 2000;21(5):405-14.
Clemente, MG et al. Immune reaction against the cytoskeleton in coeliac disease. Gut. Oct. 2000;47(4):520-6.
Taguchi, S. et al. Substrate specificity analysis of microbial transglutaminase using proteinaceous protease inhibitors as natural model substrates. J Biochem (Tokyo) Sep. 2000;128(3):415-25.
Suzuki, Y. et al. Localization of porcine trappin-2 (SKALP/elafin) in trachea and large intestine by in situ hubridization and immunohistochemistry. Histochem Cell Biol. Jul. 2000;114(1):15-20.
Yamaguchi, S. et al. A novel protein-deamidating enzyme fromChryseobacterium proteolyticumsp. nov., a newly isolated bacterium from soil. Appl Environ Microbiol. Aug. 2000;66(8):3337-43.
Yokoyama, KI et al: Overproduction of microbial transglutaminase inEscherichia coli, in vitro refolding, and characterization of the refolded form. Biosci Biotechnol Biochem. Jun. 2000;64(6):1263-70.
Bechtold, U. et al. Enzymic preparation of protein G-peroxidase conjugates catalysed by transglutaminase. J Biochem (Tokyo). Feb. 2000;127(2):239-45.
Schmidt, G. et al. Identification of the C-terminal part ofBordetella dermonecrotictoxin as a transglutaminase for rho GTPases. J Biol Chem. Nov. 5, 1999;274(45):31875-81.
Yokoyama, K. et al. Overproduction of DriaJ inEscherichia coliimproves in vivo solubility of the recombinant fish-derived transglutaminase. Biosci Biotechnol Biochem. Jun. 1998;62(6):1205-10.
Makarova, KS et al. A superfamily of archaeal, bacterial, and eukaryotic proteins homologous to animal transglutaminases. Protein Sci. Aug. 1999;8(8):1714-9.
Kobayashi, K. et al. Molecular cloning of the transglutaminase gene fromBacillus subtilisand its expression ofEscherichia coli.Biosci Biotechnol Biochem. Jun. 1998;62(6):1109-14.
Pasternack et al. A fluorescent substrate of transglutaminase for detection
LandOfFree
Method of producing polyvalent antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of producing polyvalent antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of producing polyvalent antigens will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4072282